The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACR/EULAR APS Classification Criteria Collaborators

Open source

DOI: 10.1002/art.42624
Published: 2023 Oct
Container: Arthritis & rheumatology (Hoboken, N.J.)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/art.42624,
  title = {The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.},
  author = {Barbhaiya M and Zuily S and Naden R and Hendry A and Manneville F and Amigo MC and Amoura Z and Andrade D and Andreoli L and Artim-Esen B and Atsumi T and Avcin T and Belmont HM and Bertolaccini ML and Branch DW and Carvalheiras G and Casini A and Cervera R and Cohen H and Costedoat-Chalumeau N and Crowther M and de Jesus G and Delluc A and Desai S and De Sancho M and Devreese KM and Diz-Kucukkaya R and Duarte-Garcia A and Frances C and Garcia D and Gris JC and Jordan N and Leaf RK and Kello N and Knight JS and Laskin C and Lee AI and Legault K and Levine SR and Levy RA and Limper M and Lockshin MD and Mayer-Pickel K and Musial J and Meroni PL and Orsolini G and Ortel TL and Pengo V and Petri M and Pons-Estel G and Gomez-Puerta JA and Raimboug Q and Roubey R and Sanna G and Seshan SV and Sciascia S and Tektonidou MG and Tincani A and Wahl D and Willis R and Yelnik C and Zuily C and Guillemin F and Costenbader K and Erkan D and ACR/EULAR APS Classification Criteria Collaborators},
  year = {2023},
  journal = {Arthritis \& rheumatology (Hoboken, N.J.)},
  doi = {10.1002/art.42624},
  url = {https://doi.org/10.1002/art.42624}
}

RIS

TY  - JOUR
TI  - The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
AU  - Barbhaiya M
AU  - Zuily S
AU  - Naden R
AU  - Hendry A
AU  - Manneville F
AU  - Amigo MC
AU  - Amoura Z
AU  - Andrade D
AU  - Andreoli L
AU  - Artim-Esen B
AU  - Atsumi T
AU  - Avcin T
AU  - Belmont HM
AU  - Bertolaccini ML
AU  - Branch DW
AU  - Carvalheiras G
AU  - Casini A
AU  - Cervera R
AU  - Cohen H
AU  - Costedoat-Chalumeau N
AU  - Crowther M
AU  - de Jesus G
AU  - Delluc A
AU  - Desai S
AU  - De Sancho M
AU  - Devreese KM
AU  - Diz-Kucukkaya R
AU  - Duarte-Garcia A
AU  - Frances C
AU  - Garcia D
AU  - Gris JC
AU  - Jordan N
AU  - Leaf RK
AU  - Kello N
AU  - Knight JS
AU  - Laskin C
AU  - Lee AI
AU  - Legault K
AU  - Levine SR
AU  - Levy RA
AU  - Limper M
AU  - Lockshin MD
AU  - Mayer-Pickel K
AU  - Musial J
AU  - Meroni PL
AU  - Orsolini G
AU  - Ortel TL
AU  - Pengo V
AU  - Petri M
AU  - Pons-Estel G
AU  - Gomez-Puerta JA
AU  - Raimboug Q
AU  - Roubey R
AU  - Sanna G
AU  - Seshan SV
AU  - Sciascia S
AU  - Tektonidou MG
AU  - Tincani A
AU  - Wahl D
AU  - Willis R
AU  - Yelnik C
AU  - Zuily C
AU  - Guillemin F
AU  - Costenbader K
AU  - Erkan D
AU  - ACR/EULAR APS Classification Criteria Collaborators
PY  - 2023
JO  - Arthritis & rheumatology (Hoboken, N.J.)
DO  - 10.1002/art.42624
UR  - https://doi.org/10.1002/art.42624
ER  -

APA

M, B., S, Z., R, N., A, H., F, M., MC, A., Z, A., D, A., L, A., B, A., T, A., T, A., HM, B., ML, B., DW, B., G, C., A, C., R, C., H, C., N, C., M, C., G, D. J., A, D., S, D., M, D. S., KM, D., R, D., A, D., C, F., D, G., JC, G., N, J., RK, L., N, K., JS, K., C, L., AI, L., K, L., SR, L., RA, L., M, L., MD, L., K, M., J, M., PL, M., G, O., TL, O., V, P., M, P., G, P., JA, G., Q, R., R, R., G, S., SV, S., S, S., MG, T., A, T., D, W., R, W., C, Y., C, Z., F, G., K, C., D, E., & Collaborators, A. A. C. C. (2023). The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.. Arthritis & rheumatology (Hoboken, N.J.). https://doi.org/10.1002/art.42624

Source records

pubmed · retrieved 2026-09-26T21:40:05.666Z